Moving Forward in Multiple Myeloma: Earlier Lines of CAR-T Cell Therapy
Three years after the first FDA approval of CAR-T cell therapy, patients with multiple myeloma are starting to see the therapy emerge in earlier lines.
Speeding Up With CAR-T Cell Therapy in Multiple Myeloma
CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment.
